Brain Advance Access originally published online on June 23, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Brain, Vol. 126, No. 8, 1873-1882,
August 2003
© 2003 Guarantors of Brain
doi: 10.1093/brain/awg171
Lack of IL-6 augments inflammatory response but decreases vascular permeability in bacterial meningitis
1 Department of Neurology, Ludwig-Maximilians-University, Klinikum Großhadern, 2 Department of Neurology, Heinrich-Heine Universität, Dusseldorf, Germany, 3 Section of Clinical Immunology, Department of Internal Medicine, University Hospital Zurich and 4 Basel Institute for Immunology, Basel, Switzerland
Correspondence to: Hans-Walter Pfister, MD, Department of Neurology, Klinikum Großhadern, Ludwig-Maximilians-University of Munich, Marchioninistrasse 15, 81377 Munich, Germany E-mail: pfister{at}nefo.med.uni-muenchen.de
Interleukin (IL)-6 is a multifunctional cytokine with diverse actions and has been implicated in the pathophysiology of many neurological and inflammatory disorders. In this study, we investigated the role of IL-6 in pneumococcal meningitis. Cerebral infection in wild-type (WT) mice caused an increase in vascular permeability and intracranial pressure (ICP), which were significantly reduced in IL-6–/– mice. In contrast, meningitis in IL-6–/– mice was associated with a significant increase in CSF white blood cell count compared with infected WT mice, indicating an enhanced inflammatory response. Analysis of mRNA expression in the brain showed an increase in tumour necrosis factor (TNF)-
, IL-1ß, and macrophage inflammatory protein 2 (MIP-2) levels, but decreased expression of granulocyte–macrophage colony-stimulating factor in infected IL-6–/– mice compared with infected WT controls. Similar results were obtained when rats challenged with pneumococci were systemically treated with neutralizing anti-IL-6 antibodies, resulting in an increased pleocytosis but at the same time a reduction of vascular permeability, brain oedema formation, and ICP, which was not accompanied by a downregulation of matrix metalloproteinases. Our data indicate that IL-6 plays an important anti-inflammatory role in bacterial meningitis by reducing leukocyte infiltration but contributes to the rise in intracranial pressure by increasing blood–brain barrier (BBB) permeability. These findings suggest that the migration of leukocytes across the BBB and the increase in vascular permeability are two independent processes during bacterial meningitis.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. van de Beek and E. F. M. Wijdicks Stroke Secondary to Meningococcal Meningitidis: A Potential Link Between Endothelial Dysfunction and Cytokines--Reply Arch Neurol, February 1, 2008; 65(2): 284 - 284. [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. P. Smith, J. Li, K. Garbett, K. Mirnics, and P. H. Patterson Maternal Immune Activation Alters Fetal Brain Development through Interleukin-6 J. Neurosci., October 3, 2007; 27(40): 10695 - 10702. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Wang, S. Srinivasan, A. L. Theiss, D. Merlin, and S. V. Sitaraman Interleukin-6 Induces Keratin Expression in Intestinal Epithelial Cells: POTENTIAL ROLE OF KERATIN-8 IN INTERLEUKIN-6-INDUCED BARRIER FUNCTION ALTERATIONS J. Biol. Chem., March 16, 2007; 282(11): 8219 - 8227. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. W. Phares, R. B. Kean, T. Mikheeva, and D. C. Hooper Regional differences in blood-brain barrier permeability changes and inflammation in the apathogenic clearance of virus from the central nervous system. J. Immunol., June 15, 2006; 176(12): 7666 - 7675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. G. Zwijnenburg, T. van der Poll, J. J. Roord, and A. M. van Furth Chemotactic Factors in Cerebrospinal Fluid during Bacterial Meningitis Infect. Immun., March 1, 2006; 74(3): 1445 - 1451. [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Huber, C. R. Campos, K. S. Mark, and T. P. Davis Alterations in blood-brain barrier ICAM-1 expression and brain microglial activation after {lambda}-carrageenan-induced inflammatory pain Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H732 - H740. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. W. van Ginkel, R. J. Jackson, N. Yoshino, Y. Hagiwara, D. J. Metzger, T. D. Connell, H. L. Vu, M. Martin, K. Fujihashi, and J. R. McGhee Enterotoxin-Based Mucosal Adjuvants Alter Antigen Trafficking and Induce Inflammatory Responses in the Nasal Tract Infect. Immun., October 1, 2005; 73(10): 6892 - 6902. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Echchannaoui, K. Frei, M. Letiembre, R. M. Strieter, Y. Adachi, and R. Landmann CD14 deficiency leads to increased MIP-2 production, CXCR2 expression, neutrophil transmigration, and early death in pneumococcal infection J. Leukoc. Biol., September 1, 2005; 78(3): 705 - 715. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Diao and M. Kohanawa Endogenous Interleukin-6 Plays a Crucial Protective Role in Streptococcal Toxic Shock Syndrome via Suppression of Tumor Necrosis Factor Alpha Production Infect. Immun., June 1, 2005; 73(6): 3745 - 3748. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Koedel, T. Rupprecht, B. Angele, J. Heesemann, H. Wagner, H.-W. Pfister, and C. J. Kirschning MyD88 is required for mounting a robust host immune response to Streptococcus pneumoniae in the CNS Brain, June 1, 2004; 127(6): 1437 - 1445. [Abstract] [Full Text] [PDF]
|
|